Neurology: Comparative effect of statins on the risk of incident Alzheimer disease

Neurology: Comparative effect of statins on the risk of incident Alzheimer disease is organized by American Academy of Neurology (AAN).

Released: 1/16/2018
Expires: 1/16/2021

Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by Sinyavskaya et al, the participant should be able to:
• Describe differences in the risk of developing Alzheimer disease (AD) among patients taking fungus-based vs synthetic statin medications in this study
• Identify specific statin formulations that were associated with a higher risk of AD in this study
• Discuss differences in AD risk seen across different statin potency and different statin lipophilicity seen in this study.